Reema Narayan

Reema Narayan

Auto-generated profile, based on publicly available information

Reema Narayan

Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal University, Manipal 576104, India

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2016 in Life Sciences
Verified
Journal Article
Closed access
RNReema Narayan
Reema Narayan
MSMohan Singh
Mohan Singh
OROmPrakash Ranjan
OmPrakash Ranjan
UNUsha Y Nayak
Usha Y Nayak
Sanjay GargSanjay Garg
Sanjay Garg
UNUsha Y Nayak
Usha Y Nayak

4 March 2020 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
GAGururaj C. Aithal
Gururaj C. Aithal
RNReema Narayan
Reema Narayan
UNUsha Y Nayak
Usha Y Nayak
Recently, the delivery of hydrophobic/ poorly water-soluble drugs has been a challenging task. Various strategies have been developed to counter the former along with other prime issues, such as stability, bioavailability etc. However, only few formulations have been successful in addressing the problems and nanoemulgel is a standout among them. Nanoemulgels are appropriate candidates for drug delivery because of their dual character i.e. the presence of an emulsion in the nano scale and a gel base, both combined as a single formulation. The nanoemulsion component of the nanoemulgel conforms protection to the active moiety by preventing the enzymatic degradation and certain reactions like hydrolysis. The gel base attributes thermodynamic stability to the emulsion by increasing the viscosity of the aqueous phase by decreasing the interfacial and surface tension. Nanoemulgels possess rheological characteristics which are suited especially for topical delivery and other forms such as dental delivery with the aid of better patient acceptance. As the globule size is present in the nano form alongside the employment of certain penetration enhancers can increase the effectiveness of the formulation by enhancing the permeability and diffusibility. Reports suggest that certain commercially available topical dosage forms have a low spreading coefficient in comparison with the nanoemulgel thereby focusing on the application of nanoemulgels in the field of dermatology, although paving way for various other fields have not been thoroughly exploited. This comprehensive review highlights the benefits of nanoemulgel as a potential carrier for drug delivery with an overview of few illustrations supporting the cause.

1 July 2017 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
RNReema Narayan
Reema Narayan
APAbhyuday Pednekar
Abhyuday Pednekar
DBDipshikha Bhuyan
Dipshikha Bhuyan
CGChaitra Gowda
Chaitra Gowda
KKKb Koteshwara
Kb Koteshwara
UNUsha Y Nayak
Usha Y Nayak
The aim of the present work was to tackle the solubility issue of a biopharmaceutics classification system (BCS)-II drug, aceclofenac. Although a number of attempts to increase the aqueous solubility have been made, none of the methods were taken up for scale-up. Hence size reduction technique by a top-down approach using wet milling process was utilized to improve the solubility and, consequently, the dissolution velocity of aceclofenac. The quality of the final product was ensured by Quality by Design approach wherein the effects of critical material attributes and critical process parameters were assessed on the critical quality attributes (CQAs) of nanocrystals. Box–Behnken design was applied to evaluate these effects on critical quality attributes. The optimized nanocrystals had a particle size of 484.7±54.12 nm with a polydispersity index (PDI) of 0.108±0.009. The solid state characterization of the formulation revealed that the crystalline nature of the drug was slightly reduced after the milling process. With the reduced particle size, the solubility of the nanocrystals was found to increase in both water and 0.1 N HCl when compared with that of unmilled pure aceclofenac. These results were further supported by in vitro release studies of nanocrystals where an appreciable dissolution velocity with 100.07%±2.38% release was observed for aceclofenac nanocrystals compared with 47.66%±4.53% release for pure unmilled aceclofenac at the end of 2 h. The in vivo pharmacokinetic data generated showed a statistically significant increase in the Cmax for aceclofenac nanocrystals of 3.75±0.28 µg/mL (for pure unmilled aceclofenac Cmax was 1.96±0.17 µg/mL). The results obtained indicated that the developed nanocrystals of aceclofenac were successful in improving the solubility, thus the absorption and bioavailability of the drug. Hence, it may be a viable and cost-effective alternative to the current therapy.

1 August 2017 in Life Sciences
Verified
Journal Article
Closed access
VAVasif Ahammed
Vasif Ahammed
RNReema Narayan
Reema Narayan
JPJohn Paul
John Paul
UNUsha Y Nayak
Usha Y Nayak
BRBisakha Roy
Bisakha Roy
UNUsha Y Nayak
Usha Y Nayak

1 April 2016 in Advanced Science Letters
Verified
Journal Article
Closed access
RNReema Narayan
Reema Narayan
ZAZenab Attari
Zenab Attari
MRM. Sreenivasa Reddy
M. Sreenivasa Reddy
KKK. B Koteshwara
K. B Koteshwara

1 January 2016 in Research Journal of Pharmacy and Technology
Verified
Journal Article
Closed access
ANAnuj Narang
Anuj Narang
UNUsha Y Nayak
Usha Y Nayak
BRBisakha Roy
Bisakha Roy
RNReema Narayan
Reema Narayan